Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

N. Shah; S. Rauenzahn; L. Veltri; S. Wen; M. Craig; M. Hamadani; A. S. Kanate; A. Cumpston

doi:10.1038/bmt.2016.275

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

N. Shah, S. Rauenzahn, L. Veltri, S. Wen, M. Craig, M. Hamadani, A. S. Kanate, A. Cumpston

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	321-322
Number of pages	2
Journal	Bone Marrow Transplantation
Volume	52
Issue number	2
DOIs	https://doi.org/10.1038/bmt.2016.275
State	Published - Feb 1 2017
Externally published	Yes

ASJC Scopus subject areas

Transplantation
Hematology

Access to Document

10.1038/bmt.2016.275

Cite this

@article{e1298c60e6b9495d9393aed43c52c396,

title = "Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)",

author = "N. Shah and S. Rauenzahn and L. Veltri and S. Wen and M. Craig and M. Hamadani and Kanate, {A. S.} and A. Cumpston",

year = "2017",

month = feb,

day = "1",

doi = "10.1038/bmt.2016.275",

language = "English (US)",

volume = "52",

pages = "321--322",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

AU - Shah, N.

AU - Rauenzahn, S.

AU - Veltri, L.

AU - Wen, S.

AU - Craig, M.

AU - Hamadani, M.

AU - Kanate, A. S.

AU - Cumpston, A.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=84997822155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997822155&partnerID=8YFLogxK

U2 - 10.1038/bmt.2016.275

DO - 10.1038/bmt.2016.275

M3 - Letter

C2 - 27892948

AN - SCOPUS:84997822155

SN - 0268-3369

VL - 52

SP - 321

EP - 322

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 2

ER -

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this